CCS(CCS)
CCS
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $3.77B | $3.96B |
| Low | $3.76B | $3.95B |
| High | $3.79B | $3.98B |
| EBITDA Avg | $446M | $469M |
| Low | $444M | $467M |
| High | $448M | $470M |
| EBIT Avg | $430M | $452M |
| Low | $429M | $450M |
| High | $432M | $454M |
| Net Income Avg | $149M | $167M |
| Low | $148M | $166M |
| High | $150M | $168M |
| EPS Avg | $4.91 | $5.50 |
| Low | $4.88 | $5.48 |
| High | $4.94 | $5.53 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $950M | $1.11B | $799M | $975M | $992M | $1.18B |
| Low | $947M | $1.10B | $797M | $972M | $989M | $1.18B |
| High | $953M | $1.11B | $801M | $978M | $995M | $1.18B |
| EBITDA Avg | $112M | $131M | $94M | $115M | $117M | $140M |
| Low | $112M | $130M | $94M | $115M | $117M | $139M |
| High | $113M | $131M | $95M | $116M | $118M | $140M |
| EBIT Avg | $108M | $126M | $91M | $111M | $113M | $135M |
| Low | $108M | $126M | $91M | $111M | $113M | $134M |
| High | $109M | $127M | $91M | $112M | $114M | $135M |
| Net Income Avg | $36M | $44M | $20M | $34M | $36M | $42M |
| Low | $35M | $44M | $20M | $34M | $36M | $42M |
| High | $36M | $44M | $20M | $35M | $36M | $42M |
| EPS Avg | $1.23 | $1.51 | $0.69 | $1.19 | $1.25 | $1.45 |
| Low | $1.23 | $1.50 | $0.69 | $1.19 | $1.24 | $1.44 |
| High | $1.23 | $1.52 | $0.69 | $1.19 | $1.26 | $1.46 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |